Skip to main content
logo
Aspen Neuroscience, Inc. (ASPE)
NASDAQ: ASPE · Real-Time Price · USD
11.58
-1.19 (-9.29%)
At close: Nov 5, 2026, 4:00 PM EST
11.99
+0.42 (3.59%)
After-hours: Nov 5, 2026, 4:15 PM EST

Aspen Neuroscience Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
21.2982.115.22
Short-Term Investments
51.0928.642.46
Cash & Short-Term Investments
72.38110.757.68
Cash Growth
-91.91%-
Prepaid Expenses
2.221.691.91
Total Current Assets
74.6112.3959.59
Property, Plant & Equipment
29.3227.4323.14
Long-Term Deferred Charges
2.590.060.51
Other Long-Term Assets
2.832.841.47
Total Assets
110.28143.6690.21

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
5.542.640.85
Accrued Expenses
7.17.618.13
Current Portion of Leases
3.583.533.43
Other Current Liabilities
0.130.491.63
Total Current Liabilities
16.3514.2614.04
Long-Term Leases
6.197.6710.4
Other Long-Term Liabilities
--0.02
Total Liabilities
22.5421.9324.46

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Common Stock
000
Additional Paid-In Capital
13.8511.258.52
Retained Earnings
-264.89-228.34-166.28
Comprehensive Income & Other
-0.040.010.04
Total Common Equity
-251.07-217.08-157.73
Shareholders' Equity
87.74121.7365.75
Total Liabilities & Equity
110.28143.6690.21

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
9.7711.213.83
Net Cash (Debt)
62.6199.543.85
Net Cash Growth
-126.89%-
Net Cash Per Share
5.909.644.73
Filing Date Shares Outstanding
29.0810.619.26
Total Common Shares Outstanding
10.9610.619.26
Working Capital
58.2498.1245.55
Book Value Per Share
-22.90-20.45-17.03
Tangible Book Value
-251.07-217.08-157.73
Tangible Book Value Per Share
-22.90-20.45-17.03
Machinery
10.759.147.6
Construction In Progress
11.048.651.94
Leasehold Improvements
5.655.655.65
SEC Filings: 10-K · 10-Q